C4 Therapeutics Inc (CCCC) earnings · rev $35.9M
These earnings events as JSON? API free 100/dayC4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
This CCCC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CCCC revenue for 2025-12-31 was $35.9M. Net income was -$105.0M. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. CCCC currently screens at market cap $425.7M.
When the next CCCC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 1.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CCCC research stays on the stock page; the tape stays on the quote page.
CCCC earnings FAQ
What are CCCC's latest revenue and net income?
Latest cached C4 Therapeutics Inc (CCCC) revenue for Dec 31, 2025 was $35.9M. Net income was -$105.0M. Statements: https://lician.com/financials/cccc
What is CCCC's latest diluted EPS?
Latest cached C4 Therapeutics Inc (CCCC) diluted EPS for Dec 31, 2025 was -$1.27.
What period does the latest CCCC earnings print cover?
The latest cached C4 Therapeutics Inc (CCCC) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CCCC revenue change from the prior cached period?
Cached C4 Therapeutics Inc (CCCC) revenue was up 1.0% from $35.6M (Dec 31, 2024) to $35.9M (Dec 31, 2025). Statements: https://lician.com/financials/cccc
Where are CCCC earnings listed?
Cached earnings facts for C4 Therapeutics Inc (CCCC) are listed at https://lician.com/earnings/cccc. Statements: https://lician.com/financials/cccc
Not investment advice.